ACB
$4.81
Aurora Cannabis
$.10
2.12%
ACB
Earnings Whisper ®
N/A
4th Quarter March 2025
Consensus:  $0.11
Revenue:  $59.38 Mil
Wednesday
May 7
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Wednesday, February 5, 2025

What do you expect when ACB reports earnings?
Beat
Meet
Miss

Where is ACB's stock price going from here?
Up
Flat
Down
Stock chart of ACB
Analysts
Summary of analysts' recommendations for ACB
Score
Grade
Pivots
Resistance
$5.21
$5.10
$4.96

$4.85

Support
$4.71
$4.60
$4.46
Tweet
Growth
Description
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents.